Imma Health

IMMA Health is revolutionizing IVF care by enabling fully remote fertility monitoring through an at-home, self-operated transvaginal ultrasound system that delivers automated, physician-grade reports directly to clinics. By eliminating repeated in-clinic ultrasound visits—the key bottleneck in IVF—IMMA improves access, patient experience, and clinic efficiency while increasing monitoring quality and clinical decision-making. Its B2B2C platform combines robotics, advanced ultrasound, AI-based image processing, and secure connectivity, keeping clinics at the center of care. With strong clinical validation, a clear FDA 510(k) pathway, LOIs from leading medtech players, $33M in signed pre-orders, and $1.2M raised to date, IMMA is raising a $5M seed round to complete its V1 product and reach first commercialization within 24 months.